Literature DB >> 30017311

Disparities in hepatitis C virus infection screening among Baby Boomers in the United States.

Mona Nili1, Lucy Luo1, Xue Feng1, Jongwha Chang2, Xi Tan3.   

Abstract

BACKGROUND: The study objective was to identify potential sociodemographic disparities in hepatitis C virus (HCV) infection screening among Baby Boomers in the United States.
METHODS: We analyzed cross-sectional data from the 2013-2016 National Health Interview Survey. The outcome was whether a person had an HCV infection screening (yes/no). Key independent variables were race/ethnicity, geographic region, poverty level, education level, and health insurance status. Multivariate logistic regression was performed to examine the factors associated with the receipt of HCV screening.
RESULTS: The study sample included a total of 41,914 United States Baby Boomers, who represented a population size of 69,554,339. In 2016, the HCV screening rate among Baby Boomers was 13.9%. In the multivariate logistic regression, we found that Asians had 27% lower odds of receiving an HCV screening compared to Blacks (odds ratio [OR] = 0.74, P = .02). People who lived in the Northeast, South, and West had a higher likelihood of having an HCV screening than those who lived in the Midwest (OR = 1.33, 1.39, and 1.69, respectively; all P values <.001). Additionally, people with less education, lower income, and private health insurance were significantly less likely to have an HCV screening.
CONCLUSION: Future studies or interventions are needed to target these disadvantaged populations to improve HCV screening in Baby Boomers.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baby Boomer; Geography; Health disparity; Hepatitis C virus infection screening; National Health Interview Survey; Race/ethnicity

Mesh:

Year:  2018        PMID: 30017311     DOI: 10.1016/j.ajic.2018.06.008

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  The HCV Treatment Cascade: Race Is a Factor to Consider.

Authors:  Maya Balakrishnan; Fasiha Kanwal
Journal:  J Gen Intern Med       Date:  2019-10       Impact factor: 5.128

2.  Testing for Hepatitis C Virus Infection Among Adults Aged ≥18 in the United States, 2013-2017.

Authors:  Hope King; J E Soh; William W Thompson; Jessica Rogers Brown; Karina Rapposelli; Claudia Vellozzi
Journal:  Public Health Rep       Date:  2021-10-04       Impact factor: 3.117

Review 3.  New Face of Hepatitis C.

Authors:  Tiffany Wu; Peter G Konyn; Austin W Cattaneo; Sammy Saab
Journal:  Dig Dis Sci       Date:  2019-02-13       Impact factor: 3.487

4.  Analysis of the association between areal socioeconomic deprivation levels and viral hepatitis B and C infections in Japanese municipalities.

Authors:  Tasuku Okui; Naoki Nakashima
Journal:  BMC Public Health       Date:  2022-04-07       Impact factor: 3.295

5.  Sustained Impact of the Coronavirus Disease 2019 Pandemic on Hepatitis C Virus Treatment Initiations in the United States.

Authors:  Martin Hoenigl; Daniela Abramovitz; Ricardo E Flores Ortega; Natasha K Martin; Nancy Reau
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.